MM
MMS.AX
—
ASX
Business Support Services
McMillan Shakespeare Ltd
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
12,50 %
Op margin
30,8 %
ROE
84,5 %
Net margin
16,9 %
Debt / equity
6,72
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
2026-11-09
Ex-dividend
—
TR 1Y
—
About
McMillan Shakespeare Ltd provides banking and investment services, primarily focused on consumer lending.
Business. McMillan Shakespeare Ltd (MMS.AX) is an Australian consumer lending company headquartered in Australia and listed on the Australian Securities Exchange. The firm operates within the Banking & Investment Services industry, providing banking services primarily focused on consumer lending. Specific details regarding operating segments and geographic revenue mix are not available.
Classification99 %
SectorIndustrials
Industry groupBusiness Support Services
Generated · model-assisted
Sell-side consensus
BUY6 analysts
3 buy3 hold0 sell
Avg 12m price target18,00
Analyst recommendations
6 analysts · consensus BuyBuy3
Hold3
Sell0
12-month price target
18,00
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
6 analysts · indicative
Ownership
—
not yet wired
Profitability→
84,5 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to MMS.AX. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsFY 2026 earnings (expected)2026-11-09 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
McMillan Shakespeare Ltd (MMS.AX) is an Australian consumer lending company headquartered in Australia and listed on the Australian Securities Exchange. The firm operates within the Banking & Investment Services industry, providing banking services primarily focused on consumer lending. Specific details regarding operating segments and geographic revenue mix are not available.
Classification99 %
SectorIndustrials
Industry groupBusiness Support Services
AI synthesis
GENERATEDMcMillan Shakespeare Ltd operates with a highly leveraged capital structure, as evidenced by a debt-to-equity ratio of 6.72, significantly above the median for the Consumer Lending industry. The company's liquidity position is constrained, with a current ratio of 1.05 and negative net cash after subtracting total debt. Free cash flow of 54.34 million AUD is positive but insufficient to cover long-term debt of 758.36 million AUD.
Profitability metrics show a return on equity of 84.52%, which is strong compared to the industry median, but return on assets of 6.44% is below the typical range for a capital-intensive sector like consumer lending. Operating income of 173.64 million AUD and net income of 95.34 million AUD indicate a healthy margin, but the company's high leverage amplifies the risk of earnings volatility.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The absence of segment-specific revenue data limits the ability to assess the resilience of different parts of the business.
Growth trajectory is mixed. Revenue of 563.48 million AUD in the latest period shows a stable but non-explosive trend. Analysts project a mean price target of 18.00 AUD, with a median of 17.95 AUD, suggesting limited upside potential. The company's capital expenditure of -19.29 million AUD indicates a focus on cost control rather than expansion.
Risk factors include medium liquidity risk due to the current ratio and negative net cash position. The risk assessment also flags dilution as low, but the company's high debt load and negative operating cash flow of -59.70 million AUD suggest potential refinancing challenges. No dilution sources are explicitly disclosed in the latest filings, but the company's capital structure leaves room for future equity issuance.
Recent events include a stable analyst recommendation with three "Buy" and three "Hold" ratings, and a mean recommendation of 2.50. No material events or earnings call transcripts are disclosed in the latest data, limiting insight into management's strategic direction.
Key takeaways
- High debt-to-equity ratio (6.72) indicates significant leverage risk.
- Strong ROE (84.52%) but weak ROA (6.44%) suggests asset underutilization.
- Negative operating cash flow (-59.70 million AUD) raises liquidity concerns.
- Analysts project limited upside with a mean price target of 18.00 AUD.
- No geographic or segment diversification increases concentration risk.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
A$19,42
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
A$112.8M
Net cashⓘ
-A$758.1M
Current ratioⓘ
1.1
Debt / equityⓘ
6.7
ROAⓘ
6.4%
ROEⓘ
84.5%
Cash conversionⓘ
-63.0%
CapEx / revenueⓘ
-3.4%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships23 disclosed relationships · 1 type · extracted from filings & disclosures
Subsidiaries23
EX21:14b9d968f7fdEX21:14b9d968f7fdSubsidiarie97%
EX21:15dee5b4704aEX21:15dee5b4704aSubsidiarie97%
EX21:17078d60aa29EX21:17078d60aa29Subsidiarie97%
EX21:25d8de20fe69EX21:25d8de20fe69Subsidiarie97%
EX21:2f9025403fbeEX21:2f9025403fbeSubsidiarie97%
EX21:336e20aca2b0EX21:336e20aca2b0Subsidiarie97%
EX21:35fb797407cfEX21:35fb797407cfSubsidiarie97%
EX21:3f1729900be6EX21:3f1729900be6Subsidiarie97%
EX21:493e33b68566EX21:493e33b68566Subsidiarie97%
EX21:4ad48ea31d5eEX21:4ad48ea31d5eSubsidiarie97%
EX21:5241e2609f00EX21:5241e2609f00Subsidiarie97%
EX21:6d336666f4b2EX21:6d336666f4b2Subsidiarie97%
EX21:73ad826d7280EX21:73ad826d7280Subsidiarie97%
EX21:8e9592ef0c73EX21:8e9592ef0c73Subsidiarie97%
EX21:96e327876339EX21:96e327876339Subsidiarie97%
EX21:9ed1d6bdcbd3EX21:9ed1d6bdcbd3Subsidiarie97%
EX21:b2480f8df3beEX21:b2480f8df3beSubsidiarie97%
EX21:bda24a70c9f4EX21:bda24a70c9f4Subsidiarie97%
EX21:bdd4c83fe907EX21:bdd4c83fe907Subsidiarie97%
EX21:cd62b0186096EX21:cd62b0186096Subsidiarie97%
EX21:d96c2e35373fEX21:d96c2e35373fSubsidiarie97%
EX21:dfc07b0e015eEX21:dfc07b0e015eSubsidiarie97%
EX21:f210b80352e8EX21:f210b80352e8Subsidiarie97%
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
1,50
Predicted surprise
+0,00
Beat probability
45 %
Analysts
6
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-16 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1,50 |
| Revenue | —no estimate | —no estimate | 594,3M AUD |
| Operating income | —no estimate | —no estimate | 152,8M AUD |
Full-year consensus mean (period as reported by source) · consensus in AUD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution6 analysts
Strong buy0
Buy3
Hold3
Sell0
Strong sell0
12-month price targetA$18,00 · Median A$17,95
Low A$16,40High A$19,90
Operating income · consensus152,8M AUD
EPS surprise
−1,7 %
reported vs consensus · miss
Revenue surprise
−5,2 %
reported vs consensus · miss
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
LowA$16,40
MeanA$18,00
MedianA$17,95
HighA$19,90
SpotA$19,42
−7.3 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin30,8 %Best in class
Net Margin16,9 %Above P75
ROE84,5 %Best in class
Capex / Rev-3,4 %Below median
D/E6,72Bottom quartile
Cash Conv-0,63Bottom quartile
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
Source documents
- McMillan Shakespeare Ltd Market data — financials · 2026-05-28
- McMillan Shakespeare Ltd Market data — analyst estimates · 2026-05-28
Ownership & reference
Insider activity
Net selling5 buys · 2 sellsnet -$76K12 insiders · last 365d
- Director · Common StockSold 742 @ $72,25$54K · 2026-03-17
- Director · Common StockOther 7 009 · 2026-03-10
- Director · Common StockOther 3 062 · 2026-03-10
- Director · Common StockOther 2 246 · 2026-03-10
- Director · Common StockOther 2 246 · 2026-03-10
- Director · Common StockOther 3 215 · 2026-03-10
- Director · Common StockOther 7 000 · 2026-02-27
- Director · Common StockOther 3 000 · 2026-02-24
- Director · Common StockOther 32 764 · 2026-02-18
- Director, CEO & President · Common StockBought 152 @ $76,92$12K · 2026-02-10
- Director, CEO & President · Common StockBought 1 332 @ $78,22$104K · 2026-02-10
- Director, CEO & President · Common StockBought 1 691 @ $78,77$133K · 2026-02-10
- Director · Common StockOther 32 764 · 2026-02-10
- Chief Financial Officer · Common StockBought 1 000 @ $75,62$76K · 2026-02-09
- Chief of Human Resources · Common StockSold 4 039 @ $86,84$351K · 2025-12-03
- Principal Accounting Officer · Common StockOther 1 201 · 2025-12-02
- Director, CEO & President · Common StockOther 13 391 · 2025-12-02
- Director, CEO & President · Common StockOther 39 037 @ $86,51$3,4M · 2025-12-02
- Chief Financial Officer · Common StockOther 13 391 · 2025-12-02
- Chief Financial Officer · Common StockOther 6 040 @ $86,51$522K · 2025-12-02
- General Mgr - Health & Human · Common StockOther 7 647 · 2025-12-02
- General Mgr - Health & Human · Common StockOther 3 831 @ $86,51$331K · 2025-12-02
- Principal Accounting Officer · Common StockOther 542 @ $86,51$47K · 2025-12-02
- Chief of Human Resources · Common StockOther 7 358 · 2025-12-02
- Chief of Human Resources · Common StockOther 3 319 @ $86,51$287K · 2025-12-02
Short positioning
3.1Mshares short-9.3% vs prior
5.04days to cover
71.9%short of daily vol
70fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
MMS.AXCanonical
ASX · AUD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Relationship graph
This companySectorSubsidiaries
Evidence & claims
From filings & derived data- Total assets (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 89.4%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 3.2%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 11.5%Derived (calculated)
- Current ratio (FY 2025-12-31): 2.34xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.45xDerived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 4.4%Derived (calculated)
- Current liabilities (annual): USD 608.05MSEC XBRL filing
- Current assets (annual): USD 1.42BSEC XBRL filing
- Long-term debt (annual): USD 1.51BSEC XBRL filing
- Total liabilities (annual): USD 2.49BSEC XBRL filing
- Shareholders' equity (annual): USD 1.72BSEC XBRL filing
- Shares outstanding (annual): 54.55MSEC XBRL filing
- Total assets (annual): USD 4.21BSEC XBRL filing
- Cash & equivalents (annual): USD 137.59MSEC XBRL filing
- Operating income (YoY) (2025-09-30 vs 2024-09-30): 8.1%Derived (calculated)
- Cost of revenue (YoY) (2025-09-30 vs 2024-09-30): 1.1%Derived (calculated)
- EPS (basic) (YoY) (2025-09-30 vs 2024-09-30): 10.5%Derived (calculated)
- Gross margin (FY 2025-09-30): 24.6%Derived (calculated)
- Revenue (YoY) (2025-09-30 vs 2024-09-30): 2.4%Derived (calculated)
- Net income (YoY) (2025-09-30 vs 2024-09-30): 3.9%Derived (calculated)
- Operating cash flow (YoY) (2025-09-30 vs 2024-09-30): -16.7%Derived (calculated)
- Gross profit (YoY) (2025-09-30 vs 2024-09-30): 6.5%Derived (calculated)
- Net margin (FY 2025-09-30): 5.9%Derived (calculated)
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-11-09EVENTUpcomingFY 2026 earnings (expected) estimated date
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-03-17 00:00 UTCINSIDER6 insider transactions — 2026-03
2026-03-17INSIDERMadsen Jan sold 742 sh — Director ~$54k
2026-03-10INSIDERHALEY JOHN J transacted 7.0k sh — Director
2026-03-10INSIDERAltman Anne K. transacted 3.1k sh — Director
2026-03-10INSIDERWarren Michael J. transacted 2.2k sh — Director
2026-03-10INSIDERRAJAN GAYATHRI transacted 2.2k sh — Director
2026-03-10INSIDERMadsen Jan transacted 3.2k sh — Director
2026-02-27 00:00 UTCINSIDER8 insider transactions — 2026-02 · net buy $325k
2026-02-27INSIDERMONTONI RICHARD A transacted 7.0k sh — Director
2026-02-24INSIDERMONTONI RICHARD A transacted 3.0k sh — Director
2026-02-18INSIDERHALEY JOHN J transacted 32.8k sh — Director
2026-02-10INSIDERCaswell Bruce bought 152 sh — Director, CEO & President ~$12k
2026-02-10INSIDERCaswell Bruce bought 1.3k sh — Director, CEO & President ~$104k
2026-02-10INSIDERCaswell Bruce bought 1.7k sh — Director, CEO & President ~$133k
2026-02-10INSIDERHALEY JOHN J transacted 32.8k sh — Director
2026-02-09INSIDERMutryn David bought 1.0k sh — Chief Financial Officer ~$76k
2025-12-03 00:00 UTCINSIDER18 insider transactions — 2025-12 · net sell $4.9M
2025-12-03INSIDERLink Michelle F. sold 4.0k sh — Chief of Human Resources ~$351k
2025-12-02INSIDERGOLINVAUX THERESA D transacted 1.2k sh — Principal Accounting Officer
2025-12-02INSIDERCaswell Bruce transacted 13.4k sh — Director, CEO & President
2025-12-02INSIDERCaswell Bruce transacted 39.0k sh — Director, CEO & President ~$3.38M
2025-12-02INSIDERMutryn David transacted 13.4k sh — Chief Financial Officer
2025-12-02INSIDERMutryn David transacted 6.0k sh — Chief Financial Officer ~$522k
2025-12-02INSIDERBaylinson Ilene R. transacted 7.6k sh — General Mgr - Health & Human
2025-12-02INSIDERBaylinson Ilene R. transacted 3.8k sh — General Mgr - Health & Human ~$331k
2025-12-02INSIDERGOLINVAUX THERESA D transacted 542 sh — Principal Accounting Officer ~$47k
2025-12-02INSIDERLink Michelle F. transacted 7.4k sh — Chief of Human Resources
Showing the 40 most recent of 46 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage